Search - tctmd.com

Displaying 121 - 140 of 209

Sort: Relevancy | Date

News Conference News EAS 2019

Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients

Michael O'Riordan

May 30, 2019

News Conference News EAS 2019

CHD Mortality Significantly Elevated in Patients With Severe FH

Michael O'Riordan

May 29, 2019

News Daily News

Bariatric Surgery Linked to Survival Advantage After MI and CVA

Michael O'Riordan

May 13, 2019

News Daily News

FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors

Michael O'Riordan

May 08, 2019

News Daily News

Mortality From Heart Failure Increasing in United States

Michael O'Riordan

May 06, 2019

News Daily News

EXCEL Insights: CABG Outcomes for Left Main CAD Have Improved Substantially

Michael O'Riordan

April 22, 2019

News Daily News

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

Michael O'Riordan

April 10, 2019

News Daily News

Poor Diet Responsible for 11 Million Deaths Annually, With CVD a Leading Cause

Michael O'Riordan

April 04, 2019

News Daily News

Many Statin-Eligible Patients Don’t Take Meds, and Say Doctor Is to Blame

Michael O'Riordan

March 27, 2019

News Conference News ACC 2019

Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom

Michael O'Riordan

March 20, 2019

News Conference News ACC 2019

New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead

Michael O'Riordan

March 17, 2019

News Daily News

One in Two Americans Have Cardiovascular Disease: AHA Stats

Michael O'Riordan

February 04, 2019

News Daily News

Gasp! Cardiorespiratory Fitness Falling Over Time, Duke Study Suggests

Michael O'Riordan

January 23, 2019

News Features

Top News in Prevention: 2018

Michael O'Riordan

December 28, 2018

News Daily News

Now You See It: Imaging Helps Lower CVD Risk Burden in Primary Prevention

Michael O'Riordan

December 10, 2018

News Daily News

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Michael O'Riordan

December 04, 2018

News Daily News

Higher Rates of Amputation and Ketoacidosis With SGLT2 Inhibitors: European Registry Data

Michael O'Riordan

November 26, 2018

News Daily News

PIONEER 6: Oral Semaglutide Passes Test in Cardiovascular Outcomes Study

Michael O'Riordan

November 23, 2018

News Conference News AHA 2018

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Michael O'Riordan

November 16, 2018

News Conference News AHA 2018

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Michael O'Riordan

November 14, 2018

Advertisement

Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients

CHD Mortality Significantly Elevated in Patients With Severe FH

Bariatric Surgery Linked to Survival Advantage After MI and CVA

FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors

Mortality From Heart Failure Increasing in United States

EXCEL Insights: CABG Outcomes for Left Main CAD Have Improved Substantially

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

Poor Diet Responsible for 11 Million Deaths Annually, With CVD a Leading Cause

Many Statin-Eligible Patients Don’t Take Meds, and Say Doctor Is to Blame

Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom

New Primary Prevention Guidelines Axe Aspirin, Pushing Routine Check-ins, Social Clues Instead

One in Two Americans Have Cardiovascular Disease: AHA Stats

Gasp! Cardiorespiratory Fitness Falling Over Time, Duke Study Suggests

Top News in Prevention: 2018

Now You See It: Imaging Helps Lower CVD Risk Burden in Primary Prevention

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Higher Rates of Amputation and Ketoacidosis With SGLT2 Inhibitors: European Registry Data

PIONEER 6: Oral Semaglutide Passes Test in Cardiovascular Outcomes Study

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content